As physicians get a handle on quality reporting metrics, they're turning their focus to honing their processes and reporting in order to improve patient outcomes and navigate the new payment model.
Efforts to move away from fee-for-service payment models have had virtually no impact on the latest industry data available, according to a study from Health Affairs. However, the data only extends through 2013, and therefore predate a new wave of interest in value-based payment models.
The federal government says it is ahead of schedule in its goal to tie 30 percent of Medicare payments to alternative payment models by the end of 2016.
While they sometimes have opposing interests, payers and drug companies can work together so that patients have better access to new, innovative medications, according to a Health Affairs Blog post.
Offering financial incentives to providers in a pediatric accountable care organization led to improved outcomes, according to a new study in JAMA Pediatrics. What's more, data suggest additional interventions may further enhance quality improvements.
With a small window of time before the U.S. Presidential elections take all the legislative air out of the room, medical advocacy groups are focused on advancing their top priorities. The majority of this year's goals lie in the regulatory arena, according to a story in MedPage Today.
The incredible spread of health-based technology geared toward consumers, from wearable devices to mobile apps, has generated notice among many in the medical community. A new study demonstrating the benefits of texting interventions to encourage increased physical activity among cardiology patients suggests the cell phone may be a promising--but largely untapped--clinical resource, according to an article in the Boston Globe.
Bedless hospitals. Mega hospital and insurer mergers. A growing consumer appetite for virtual health interactions. Those are among PwC's predictions for top healthcare industry trends for the new year in a report released today.
As the Centers for Medicare & Medicaid Services accelerates the move a value-based payment model, its efforts are dependent upon receiving data from health insurers to improve care delivery, says CMS Acting Administrator Andy Slavitt, according to an article from Health Data Management.
In healthcare, prescription drugs are the only major product for which the producer is able to exercise relatively unrestrained pricing power, and the result is that drug prices in the U.S. are usually two to six times higher than prices for the same drugs in other major industrialized nations, according to a perspective piece published in the Journal of American Medical Association.